Browsing: Featured

NEW YORK, Oct. 25, 2026 —  Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common…

NEW YORK, Oct. 25, 2026 — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Better Home & Finance Holding Company…

Allegedly, Sinclair Television of California, LLC failed to provide employees with  accurate itemized wage statements due to missed meal breaks. This, allegedly, has resulted in violations…

NEW YORK, Oct. 25, 2026 — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Qfin Holdings, Inc. (NASDAQ: QFIN)…

NEW YORK, Oct. 25, 2026 — Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of…

SAN DIEGO, Oct. 25, 2026 — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Gildan Activewear Inc. (NYSE: GIL)…

Did you buy FLNC securities between November 24, 2025 and September 16, 2026? Affected FLNC Investor Summary Who: Fluence Energy, Inc. (NASDAQ: FLNC) What: Securities fraud class action…

SAN DIEGO, Oct. 25, 2026 — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between…

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR…

Data presented at ESMO highlight the promising efficacy of olomorasib in combination with standard-of-care immunotherapy with or without chemotherapy in first-line advanced KRAS G12C-mutant non-small cell…